Kotarosumitomo Nakayama

Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis

Yoshihiro Kamada, Maaya Akita, Yuri Takeda et al. · PLoS ONE · 2013 · 73 citations · Full text

Medicine, Biochemistry, Pathology +17

Mutation of GDP-Mannose-4,6-Dehydratase in Colorectal Cancer Metastasis

Kotarosumitomo Nakayama, Kenta Moriwaki, Taku Imai et al. · PLoS ONE · 2013 · 47 citations · Full text

Medicine, Biochemistry, Oncology +17

Core fucose is essential glycosylation for CD14-dependent Toll-like receptor 4 and Toll-like receptor 2 signalling in macrophages

Kotarosumitomo Nakayama, Kana Wakamatsu, Hironobu Fujii et al. · The Journal of Biochemistry · 2018 · 39 citations

Life Sciences, Cell Biology, Immunology +16

Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method)

Mika Hosokawa, Hirokazu Kashiwagi, Kotarosumitomo Nakayama et al. · Transfusion · 2018 · 31 citations

Life Sciences, Hematology, Immunology +16

Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis

Koichi Morishita, Nami Ito, Sayaka Koda et al. · Clinica Chimica Acta · 2018 · 28 citations

Medicine, Biochemistry, Oncology +8